{
	"nodes":[
		{"id":"63cbada7a9c925c2","type":"group","x":-1900,"y":-400,"width":717,"height":700,"label":"基础信息"},
		{"id":"5c16154f0db6f3b3","type":"file","file":"文章/综述/assets/肿瘤浸润巨噬细胞的复杂作用/file-20260127165109208.png","x":-1880,"y":-380,"width":677,"height":340},
		{"id":"6910f17864ff7fce","type":"text","text":"\n| **期刊/年份**    | _Nature Immunology_ / 2022年                                                                                                                                    |\n| ------------ | -------------------------------------------------------------------------------------------------------------------------------------------------------------- |\n| **通讯作者**     | Vassiliki A. Boussiotis (Harvard Medical School / BIDMC)                                                                                                       |\n| **实验室/研究方向** | Boussiotis实验室    <br>- Beth Israel Deaconess Medical Center, Division of Hematology-Oncology       <br>- 长期致力于T细胞共刺激/共抑制通路（尤其是PD-1）、骨髓类细胞免疫调节及肿瘤免疫微环境（TME）的研究。 |\n| **代表性高分文章**： | - _Nature_ (2017) - PD-1 expression by TAMs inhibits phagocytosis.<br>- _Science Immunology_ (2020) - Targeted deletion of PD-1 in myeloid cells.              |\n| **PMID**     | [35879446](https://pubmed.ncbi.nlm.nih.gov/35879446/ \"null\")                                                                                                   |\n\n","x":-1880,"y":-20,"width":677,"height":300},
		{"id":"eb9e75760c37752f","type":"text","text":"- 本综述的核心逻辑在于打破了传统的“M1/M2”简单二分法。\n- 作者系统论证了 TAMs 如何从进化上保守的“组织保护者”转变为“肿瘤共犯”。\n- 其核心矛盾在于：**肿瘤劫持了本用于抗感染和组织修复的[促炎抑炎通路](文章/常识/促炎抑炎通路.md)**,通过代谢重塑和空间定位，诱导 TAMs 形成复杂的功能多样性，最终导致免疫逃逸。**","x":-1140,"y":-380,"width":534,"height":260}
	],
	"edges":[]
}